Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
Bio-Techne (NASDAQ: TECH) said Kim Kelderman, President and CEO, will present at the Bank of America Securities 2026 Global Healthcare Conference on Tuesday, May 12, 2026 at 9:20 a.m. PDT.
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) said Kim Kelderman, President and CEO, will present at the Bank of America Securities 2026 Global Healthcare Conference on Tuesday, May 12, 2026 at 9:20 a.m. PDT. A live webcast will be available via the company’s investor relations IR Calendar page.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TECH
On May 4, the day this news came out, TECH closed 0.51% below the previous close.
Data tracked by StockTitan Argus for the May 4 session.
Key Figures
- Conference time
- 9:20 a.m. PDT
- Bank of America Securities 2026 Global Healthcare Conference presentation on May 12, 2026
Historical Context
-
Streamlined brands into three portfolios debuting at major scientific meetings.
-
Set date and access details for Q3 fiscal 2026 results call.
-
Expanded COMET spatial biology suite with new panels and amplification kits.
-
Announced presentations at two early March 2026 healthcare investor conferences.
-
Ella platform received CE-IVD marking enabling EU clinical deployment.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Bio-Techne
Bio‑Techne Corporation (NASDAQ: TECH) is a global life sciences company headquartered in Minnesota, celebrating 50 years of empowering scientific and diagnostic communities to reach better answers. The company provides high‑quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer‑focused brands: R&D Systems™, Bio‑Techne Spatial™, and Bio‑Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical decision‑making. Bio‑Techne operates in 34 locations worldwide and employs approximately 3,100 people. In fiscal year 2025, the company generated over
For more information on Bio-Techne and its brands, please visit www.bio-techne.com or follow the company on social media at LinkedIn, X, or YouTube.
Contact: | David Clair, Vice President, Investor Relations |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference-302760526.html
SOURCE Bio-Techne Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
